PTGX

Protagonist Therapeutics, Inc.

$95.41

+2.18 (+2.34%)

Rating:C-

Market Metrics

Open

$93.93

Prev. Close

$93.23

Day Low

$93.00

Day High

$95.61

52W Low

$49.38

52W High

$107.84

Market Cap

$6.14B

Volume

0.55M

News SentimentBullish

Articles

Avg Positive

31.0%

Avg Negative

1.7%

Avg Neutral

67.1%

News Feed

Protagonist Therapeutics Announces Amendment of Agreement with Janssen Biotech for the Continued Development and Commercialization of IL-23 Antagonists

PRNewsWire·7/28/2021·↑ positive

Protagonist Therapeutics, Inc. Announces Closing of $132.2 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

PRNewsWire·6/18/2021·↓ negative